Amy Carroll
Increased consumption and pervasive budgetary constraints are continuing to drive investment and innovation in the healthcare industry.
No fees, no carry is a compelling reason to co-invest, but gaining access can be tough, and transacting at speed a real challenge.
Demand for co-investment is soaring as GPs seek to preserve capital and cultivate strong LP relationships in a challenging fundraising environment.
Structured solutions can provide much needed liquidity without forcing LPs to crystalize a loss.
Continuation funds could provide sponsors with more time and capital to execute transformative sustainability initiatives.
LPs are facing a difficult choice as they balance liquidity challenges with the deep discounts on offer in the secondaries market.
An understanding that responsible investing is essential to risk mitigation and value creation means ESG is playing a greater role in manager selection.
Emerging managers may be prepared to cede some ground on terms to get their first fund away, but regaining control can be challenging
Team composition, differentiated strategy and deal-sourcing prowess top investors’ emerging manager wish-list.
Despite a lack of infrastructure, emerging managers are stepping up on ESG and diversity.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: